Athira Pharma, Inc. (ATHA) Misses Q3 EPS by 155c

Athira Pharma, Inc. (NASDAQ: ATHA) reported Q3 EPS of ($1.68), $1.55 worse than the analyst estimate of ($0.13).

For earnings history and earnings-related data on Athira Pharma, Inc. (ATHA) click here.

You May Also Be Interested In

• Hawaiian Electric trades at 8.8x P/E, but wildfire risk clouds value case
• Yext, Inc. (YEXT) Tops Q2 EPS by 4c
• Designer Brands (DBI) PT Lowered to $6 at UBS